Reduction of brain damage after perinatal arterial stroke (PAS) with recombinant human erythropoietine (rhEPO): feasibility and safety study.
Completed
- Conditions
- cerebral arterial infarctionStroke10010335
- Registration Number
- NL-OMON33752
- Lead Sponsor
- Academisch Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
Perinatal arterial infarction (PAS) in the brain.
Exclusion Criteria
Congenital and/or chromosomal problems.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method